Penumbra, Inc. PEN
319.79 USD -0.83 (-0.26%)
As ofNov 17, 2026, 12:54 PM EST
319.43 Day range 320.60
276.01 52-week range 362.41
- YTD
- +2.86%
- 1 year
- +14.82%
News
benzinga.com Penumbra Q3 EPS $1.07 Misses $1.25 Estimate, Sales $410.145M Beat $403.345M Estimate Penumbra (NYSE:PEN) reported quarterly earnings of $1.07 per share which missed the analyst consensus estimate of $1.25 by 14.4 percent. This is a 10.31 percent increase over earnings of $0.97 per…
benzinga.com Penumbra Wins FDA Clearance For Lightning CAVT Technology To Treat Deep Vein Thrombosis, Backed By BOLT-DVT Trial Results BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy (CAVT) for DVT is safe and…
